Trinity Capital, a provider of diversified financial solutions to growth-oriented companies, committed $15 million in growth capital to restor3d, a 3D printing, patient specific medical device company.
“restor3d is at the forefront of innovation in the customized orthopedic implant industry with its unique patient specific 3D printed technologies,” Lauren Cosentino, managing director, life sciences at Trinity Capital, said. “We look forward to working with restor3d’s leadership team and supporting the company’s continued growth.”
The new debt facility from Trinity will allow restor3d to continue its product innovation and expansion into new markets.
“We are thrilled to partner with Trinity as we continue to scale our business and bring our innovative, patient specific medical devices to more surgeons and patients worldwide,” Kurt Jacobus, CEO of restor3d, said. “This investment underscores the immense potential of our technology to transform patient care and drive better surgical outcomes.”
